Audent Global Asset Management LLC Has $2.56 Million Holdings in iShares Biotechnology ETF $IBB

Audent Global Asset Management LLC decreased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 38.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,185 shares of the financial services provider’s stock after selling 9,432 shares during the period. iShares Biotechnology ETF makes up 2.7% of Audent Global Asset Management LLC’s portfolio, making the stock its 14th largest holding. Audent Global Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $2,564,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of IBB. Darwin Wealth Management LLC acquired a new stake in iShares Biotechnology ETF during the second quarter worth $25,000. Basepoint Wealth LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $26,000. Cary Street Partners Financial LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $29,000. Copia Wealth Management acquired a new stake in iShares Biotechnology ETF in the 4th quarter valued at $34,000. Finally, Caitlin John LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter valued at $34,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $189.76 on Friday. iShares Biotechnology ETF has a 52 week low of $128.84 and a 52 week high of $199.05. The company’s fifty day moving average is $177.79 and its 200-day moving average is $173.40.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were issued a dividend of $0.0238 per share. This represents a $0.10 annualized dividend and a yield of 0.1%. The ex-dividend date of this dividend was Monday, June 15th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.